Aggressive T-Cell Non-Hodgkin Lymphoma — Trials

Aggressive T-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

289 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 62
Recruiting: 32
Ph III recruiting: 3
Growth YoY: —
Industry share: 21%
Top sponsor: City of Hope Medical Center
Termination share: 33%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (47)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07476027	Efficacy and Safety of CD7 CAR-T in Newly Diagnosed High-Risk T-LBL/ALL	not yet recruiting	Early Phase 1	10	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	0	Mar 17, 2026	clinicaltrials
NCT01184885	A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy	completed	Early Phase 1	7	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER	1